LumiThera, Inc. Email Format
Medical Equipment ManufacturingWashington, United States11-50 Employees
LumiThera, Inc. is a small-to-midsize medical device company based in Poulsbo, Washington, focused on ophthalmic technologies that use light to detect, treat, and monitor retinal diseases, notably dry age-related macular degeneration. Its flagship therapy, the Valeda Light Delivery System, employs light across multiple wavelengths to treat dry AMD and has U.S. FDA clearance and EU CE marking, with availability in select Latin American markets. The company serves eye care providers seeking new approaches to slow disease progression and monitor patient status. The portfolio also includes AdaptDx Pro, a portable AI-assisted dark adaptometer, and the NOVA Vision Testing System, an electrophysiology platform for objective assessment of visual and neuro-visual pathways. AdaptDx Pro and NOVA are distributed through LumiThera Diagnostics, Inc. and Diopsys, Inc., respectively. In July 2025, industry reports indicated that Alcon planned to acquire LumiThera and its photobiomodulation device for early and intermediate dry AMD.